Incyte Corp [INCY] stock is trading at $67.42, up 0.46%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INCY shares have gain 3.83% over the last week, with a monthly amount glided 8.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on March 18, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, Guggenheim downgraded its rating to Neutral on March 18, 2025. On December 17, 2024, UBS initiated with a Neutral rating and assigned a price target of $77 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $90 on October 29, 2024. Wolfe Research initiated its recommendation with a Outperform and recommended $84 as its price target on October 01, 2024. Truist downgraded its rating to Hold for this stock on September 18, 2024, and downed its price target to $74. In a note dated July 02, 2024, BMO Capital Markets downgraded an Underperform rating on this stock and revised its target price from $52 to $48.
Incyte Corp [INCY] stock has fluctuated between $53.56 and $83.95 over the past year. Currently, Wall Street analysts expect the stock to reach $92 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $67.42 at the most recent close of the market. An investor can expect a potential return of 36.46% based on the average INCY price forecast.
Analyzing the INCY fundamentals
Incyte Corp [NASDAQ:INCY] reported sales of 4.41B for the trailing twelve months, which represents a growth of 19.53%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Incyte Corp’s Current Ratio is 2.04. In addition, the Quick Ratio stands at 2.00 and the Cash Ratio stands at 1.13. Considering the valuation of this stock, the price to sales ratio is 2.96, the price to book ratio is 3.56 and price to earnings (TTM) ratio is 208.60.
Transactions by insiders
Recent insider trading involved SHEILA DENTON, Officer, that happened on Jun 03 ’25 when 1795.0 shares were purchased. Principal Accounting Officer, Tray Thomas completed a deal on May 30 ’25 to sell 963.0 shares. Meanwhile, Principal Accounting Officer Tray Thomas sold 651.0 shares on Jun 02 ’25.
